US health officials are reviewing a nearly $600 million contract awarded to Moderna for bird flu vaccines in the final days ...

Novavax, Inc. faces declining revenues and high risks despite the Sanofi deal and cost-cutting measures. Click here for my ...

Moderna stock skidded on reports Robert F. Kennedy Jr. is considering pulling funding for its bird flu vaccine. Is MRNA stock ...

"The MHRA's authorization of our RSV vaccine is an important milestone for Moderna's efforts toward respiratory disease preparedness," said Stéphane Bancel, Chief Executive Officer of Moderna. "Our ...

Britain's health regulator said on Friday it has approved Moderna's vaccine for respiratory syncytial virus in adults 60 ...

The latest actions by federal health authorities overseen by Robert F. Kennedy Jr. on vaccine development and evaluation are ...

3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%.

As it did during the COVID-19 pandemic, mRNA technology offers an efficient way forward in developing products for diseases ...

Wacky Bob Kennedy and the health officials who work for him are now reevaluating a $590 million contract for bird flu shots ...

The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in ...

Moderna shares fell 3% Thursday afternoon, after reports that federal health officials are re-evaluating the company’s $590 million contract to help develop a bird-flu vaccine. Moderna was awarded the ...

Moderna Inc.'s stock tumbled 4% Thursday, after a report that health officials are reviewing a contract the company won from the Biden administration to support its efforts to develop a bird-flu ...